Skip to main content
OpenTrials
Completed

NCT Number: NCT02847507

Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)

Study of seroprevalence of hepatitis E among HIV positive patient in Basque country, France in 2016.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Digestive System Diseases Hepatitis Hepatitis E Hepatitis, Viral, Human Infections Liver Diseases RNA Virus Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre hospitalier de la Côte Basque

Bayonne, 64100, France

About this study

Study of seroprevalence of hepatitis E among patient followed and treated in "centre Hospitalier de la Côte Basque" for HIV infections. Study of acquisition of hepatitis E , and determination of liver status using fibrotest in co-infected patients with hepatis C and / or B.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HIV positive > 18

Exclusion criteria

  • patient refusal for participation

Treatment and study plan

Primary outcomes

  1. Prevalence of immunoglobulin M (IgM) and Immunoglobulin G (IgG) for hepatitis E in blood sample of each patients. Positive sample for both IgM and IgG will be confirmed using polymerase chain reaction (PCR) techniques

    Time frame: 6 months time period

    Blood samples will be tested for specific immunoglobulins against hepatitis E virus

Secondary outcomes

  1. fibrotest score

    Time frame: 6 months time period

    patients infected with hepatitis B or hepatitis C viruses will have their liver status determined using fibrotest score.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de la côte Basque

Other

Collaborators

  • University Hospital, Toulouse

Registry information

Official study title

Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb): a Prospective Cohort Study

Acronym: VIhVhEpb

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Jul 28, 2016
Registry last updated
Jul 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.